Ji, Sang Hoon <br/><br/>
Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer.  [electronic resource] 

 -  Japanese journal of clinical oncology  Apr 2005 
 - 214-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0368-2811 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyi061  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Colonic Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Irinotecan<br/>Leucovorin--administration & dosage<br/>Leukopenia--chemically induced<br/>Liver Neoplasms--secondary<br/>Lung Neoplasms--secondary<br/>Lymphatic Metastasis<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Rectal Neoplasms--drug therapy<br/>Survival Analysis<br/>Treatment Outcome